Cystatin-C as an early marker of diabetic nephropathy in diabetic patients | ||||
Research Journal of Applied Biotechnology | ||||
Article 5, Volume 1, Issue 1, June 2015, Page 54-63 PDF (437.05 K) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/rjab.2015.53528 | ||||
![]() | ||||
Authors | ||||
Khalil A. El-Halfawy* ; Fatten Zahran* ; Khaled B. Khalil* ; Aly Fahmy* ; Fatten Ibrahim* | ||||
Department of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Egypt | ||||
Abstract | ||||
Chronic kidney disease (CKD) is a major trouble in public health worldwide due to its rapid and random prevalence especially in diabetic patients. Further, diabetic nephropathy is a common cause of renal failure occurred in diabetic patients accompanied with low level of albumin in urine at early stage. Notably, early recognition of structural and functional alteration in the kidney is required and essential to identify the appropriate treatment at the beginning of renal syndromes. Several studies exhibit the essential role of serum creatinine in assessment of glomerular filtration rate (GFR) as a biomarker of renal failure. Alternatively, here findings demonstrate that level of serum cystatin-c is an efficacious candidate that can be revealing the possible alternations in renal function including children patients. Thus, blood samples collected from renal and/or diabetic patients showed contradictory relationship between serum cystatin-c level and GFR independent from diabetic syndromes. The results strongly indicate the possible exploiting of serum cystatin-c as an early indicator for renal disease. Collectively, current data further confirm the crucial role of serum cystatin-c in early detection of renal failure via reverse connection with GFR particularly in diabetic children. | ||||
References | ||||
Babiloni, C., Benussi, L., Binetti, G., Bosco, P., Busonero, G., Cesaretti, S., Dal, F.G., Del, P.C., Ferri, R., Frisoni, G., Ghidoni, R., Rodriguez, G., Squitti, R., and Rossini, P.M. (2006). Genotype (cystatin C) and EEG phenotype in Alzheimer disease and mild cognitive impairment: a multicentric study. Neuroimage. 29, 948-
Bokenkamp, A., and Herget-Rosenthal, S. (2004). Urinary cystatin C as a marker of GFR? A word of caution. Pediatr. Nephrol. 19, 1429.
Chiarelli, F., and Mohn, A. (2002). Angiopathy in children with diabetes. Minerva Pediatr. 54, 187-
Coresh, J., and Stevens, L.A. (2006). Kidney function estimating equations: where do we stand? Curr. Opin. Nephrol. Hypertens. 15, 276-
Feinfeld, D.A., Bargouthi, H., Niaz, Q., and Carvounis, C.P. (2002). Massive and disproportionate elevation of blood urea nitrogen in acute azotemia. Int. Urol. Nephrol. 34, 143-
Fekete, A., and Vannay, A. (2014). [Importance of diabetic nephropathy in childhood. Clinical findings and basic research in the past decades]. Orv. Hetil. 155, 141-
Finney, H., Newman, D.J., Thakkar, H., Fell, J.M., and Price, C.P. (2000). Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch. Dis. Child 82, -
Hartemann, A., Attal, N., Bouhassira, D., Dumont, I., Gin, H., Jeanne, S., Said, G., and Richard, J.L. (2011). Painful diabetic neuropathy: diagnosis and management. Diabetes Metab 37, 377-
Herget-Rosenthal, S., Marggraf, G., Husing, J., Goring, F., Pietruck, F., Janssen, O., Philipp, T., and Kribben, A. (2004). Early detection of acute renal failure by serum cystatin C. Kidney Int. 66, 1115-
Jiborn, T., Abrahamson, M., Wallin, H., Malm, J., Lundwall, A., Gadaleanu, V., Abrahamsson, P.A., and Bjartell, A. (2004). Cystatin C is highly expressed in the human male reproductive system. J. Androl 25, 564-
Kes, P., Basic-Jukic, N., Ljutic, D., and Brunetta-Gavranic, B. (2011). [The role of arterial hypertension in developement of chronic renal failure]. Acta Med. Croatica 65 Suppl 3, 78-
Krawczeski, C.D., Vandevoorde, R.G., Kathman, T., Bennett, M.R., Woo, J.G., Wang, Y., Griffiths, R.E., and Devarajan, P. (2010). Serum
Research Journal of Applied Biotechnology (RJAB)
cystatin C is an early predictive biomarker of acute kidney injury after pediatric cardiopulmonary bypass. Clin. J. Am. Soc. Nephrol. 5, 1552-
Levey, A.S., Bosch, J.P., Lewis, J.B., Greene, T., Rogers, N., and Roth, D. (1999). A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 130, 461-
Levey, A.S., Coresh, J., Greene, T., Stevens, L.A., Zhang, Y.L., Hendriksen, S., Kusek, J.W., and Van, L.F. (2006). Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann. Intern. Med. -
Liao, M.T., Sung, C.C., Hung, K.C., Wu, C.C., Lo, L., and Lu, K.C. (2012). Insulin resistance in patients with chronic kidney disease. J. Biomed. Biotechnol. 2012, 691369.
Lieske, J.C., Chawla, L., Kashani, K., Kellum, J.A., Jr., Koyner, J.L., and Mehta, R.L. (2013). Biomarkers for Acute Kidney Injury: Where Are We Today? Where Should We Go? Clin. Chem.
Lin, H.J., Chao, C.L., Chien, K.L., Ho, Y.L., Lee, C.M., Lin, Y.H., Wu, Y.W., Hsu, R.B., Chou, N.K., Wang, S.S., Chen, C.Y., and Chen, M.F. (2009). Elevated blood urea nitrogen-to-creatinine ratio increased the risk of hospitalization and all-cause death in patients with chronic heart failure. Clin. Res. Cardiol. 98, 487-
Lyman, J.L. (1986). Blood urea nitrogen and creatinine. Emerg. Med. Clin. North Am. 4, 223-
Madero, M., Sarnak, M.J., and Stevens, L.A. (2006). Serum cystatin C as a marker of glomerular filtration rate. Curr. Opin. Nephrol. Hypertens. -
Makela, S., Ala-Houhala, I., Mustonen, J., Koivisto, A.M., Kouri, T., Turjanmaa, V., Vapalahti, O., Vaheri, A., and Pasternack, A. (2000). Renal function and blood pressure five years after puumala virus-induced nephropathy. Kidney Int. 58, 1711-
Miettinen, M.H., Makela, S.M., Ala-Houhala, I.O., Huhtala, H.S., Koobi, T., Vaheri, A.I., Pasternack, A.I., Porsti, I.H., and Mustonen, J.T. (2006). Ten-year prognosis of Puumala hantavirus-induced acute interstitial nephritis. Kidney Int. 69, 2043-
Mustonen, J., Partanen, J., Kanerva, M., Pietila, K., Vapalahti, O., Pasternack, A., and Vaheri, A. (1996). Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int. 49, 217-
Paroni, R., Arcelloni, C., Fermo, I., and Bonini, P.A. (1990). Determination of creatinine in serum and urine by a rapid liquid-chromatographic method. Clin. Chem. 36, 830-
Perrone, R.D., Madias, N.E., and Levey, A.S. (1992). Serum creatinine as an index of renal function: new insights into old concepts. Clin. Chem. -
Research Journal of Applied Biotechnology (RJAB)
Stevens, L.A., Coresh, J., Greene, T., and Levey, A.S. (2006). Assessing kidney function--measured and estimated glomerular filtration rate. N. Engl. J. Med. 354, 2473-
Tang, M., Donaghue, K.C., Cho, Y.H., and Craig, M.E. (2013). Autonomic neuropathy in young people with type 1 diabetes: a systematic review. Pediatr. Diabetes 14, 239-
Watanabe, M., Jackson, M., Ikeda, M., Mizushima, K., Amari, M., Takatama, M., Hirai, S., Ikeda, Y., Shizuka-Ikeda, M., and Okamoto, K. (2006). Genetic analysis of the cystatin C gene in familial and sporadic ALS patients. Brain Res - -
Xie, L., Terrand, J., Xu, B., Tsaprailis, G., Boyer, J., and Chen, Q.M. (2010). Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulation. Cardiovasc. Res. 87, 628- | ||||
Statistics Article View: 199 PDF Download: 302 |
||||